The global erythromycin export market in 2023 saw China leading with 46.59%, followed by India with 21.08%, and the United States with 17.54%. Noteworthy growth was observed in Pakistan at 46.99%, and the Czech Republic at 53.26%. Conversely, the United States and Malaysia exhibited declines of 2.8% and 4.54% respectively.
Future trends to watch in the erythromycin export market include increasing Asian market dominance, particularly from China and India, alongside potential growth in Pakistan. Declines in traditional Western markets may continue, presenting opportunities for emerging markets to gain share.
Top countries in Export of Erythromycin Share by Country (Kilograms)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 46.59 | 2023 | +0.93% | +2.38% | View data |
| 2 | 2 India | 21.08 | 2023 | +2.73% | +3.36% | View data |
| 3 | 3 United States | 17.54 | 2023 | -0.69% | -2.8% | View data |
| 4 | 4 Thailand | 2.02 | 2023 | -1.54% | -1.87% | View data |
| 5 | 5 Malaysia | 1.94 | 2023 | -4.3% | -4.54% | View data |
| 6 | 6 Germany | 1.21 | 2023 | +0.016% | +1.14% | View data |
| 7 | 7 Pakistan | 1.01 | 2023 | +1.52% | +46.99% | View data |
| 8 | 8 South Korea | 0.45 | 2023 | +5.27% | +7.2% | View data |
| 9 | 9 Singapore | 0.22 | 2023 | -7.4% | -6.27% | View data |
| 10 | 10 France | 0.16 | 2023 | -8.35% | -6.09% | View data |
